Cargando…
R(x)IALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre–post intervention study
Patients with inflammatory conditions are at high risk for cardiovascular (CV) disease. Despite such elevated risk, their CV risk factors are suboptimally managed. OBJECTIVE: To evaluate the effect of a pharmacist-led intervention on CV risk in patients with inflammatory conditions. METHODS: DESIGN:...
Autores principales: | Al Hamarneh, Yazid N, Marra, Carlo, Gniadecki, Robert, Keeling, Stephanie, Morgan, Andrea, Tsuyuki, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993291/ https://www.ncbi.nlm.nih.gov/pubmed/33762234 http://dx.doi.org/10.1136/bmjopen-2020-043612 |
Ejemplares similares
-
Pharmacist intervention for glycaemic control in the community (the RxING study)
por: Al Hamarneh, Yazid N, et al.
Publicado: (2013) -
Real-world implementation of diabetes management by pharmacists: The R(X)ING Practice Tool
por: Al Hamarneh, Yazid N., et al.
Publicado: (2021) -
Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes
por: So, Randy, et al.
Publicado: (2021) -
The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial
por: Smyth, Penelope, et al.
Publicado: (2022) -
Behaviour change interventions for the management of Raynaud’s phenomenon: a systematic review protocol
por: Daniels, Jo, et al.
Publicado: (2017)